Share of global biopharmaceutical pipeline
Proportion of global biopharmaceutical research and development pipeline assets originating from a specific country or region.
Unit Percent Industry Pharmaceuticals
The chart
Over time
China over time. Forecasts are dashed with hollow markers; the underlying values are one click away under the chart.
Every record
All records
2 records · 1 region · 2015–2025
| Period | Value | Source | Type |
|---|---|---|---|
| China 2 records | |||
| 2025 | 30% | State Council · 31 Dec 2025 | actual |
| 2015 | 2% | State Council · 31 Dec 2015 | actual |
Primary documents
Sources
1 document. Each links to the publisher's own copy.
| Document | Publisher | Published | Data points |
|---|---|---|---|
| China to expand health insurance coverage for innovative drugs | State Council | — | 2 |
Cite & reuse
Cite this page
Data on this page is published under CC BY 4.0. You may reuse it, including commercially, provided you attribute it. To cite one figure, open its record: each carries APA, MLA, Chicago and BibTeX forms that credit the original publisher.
StatOrigin. (2026). Share of global biopharmaceutical pipeline. Retrieved from https://statorigin.org/indicators/share-of-global-biopharmaceutical-pipeline